Woodline Partners’s Fulcrum Therapeutics FULC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.18M | Hold |
897,617
| – | – | 0.03% | 521 |
|
|
2025
Q1 | $2.59M | Sell |
897,617
-512,903
| -36% | -$1.48M | 0.02% | 627 |
|
|
2024
Q4 | $6.63M | Buy |
1,410,520
+739,713
| +110% | +$3.48M | 0.04% | 428 |
|
|
2024
Q3 | $2.39M | Buy |
670,807
+169,506
| +34% | +$605K | 0.02% | 458 |
|
|
2024
Q2 | $3.11M | Buy |
+501,301
| New | +$3.11M | 0.03% | 381 |
|
|
2023
Q3 | – | Sell |
-596,695
| Closed | -$1.97M | – | 642 |
|
|
2023
Q2 | $1.97M | Buy |
+596,695
| New | +$1.97M | 0.02% | 431 |
|